Reagents
Ended Purchase Order Awarded Last action
- Contract number
- 75N90018P00461
- Awardee
-
Omixon, Inc. UEI DW2PPM9LS8W4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $101,220
Award facts
- Opportunity
-
- 18008609 Solicitation number
- HLA Genotyping Assays for Transfusion Medicine Award Notice · Posted Apr 23, 2018
- Contract value 100% obligated
- $101,220.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $101,220 |
About this award
The NIH Clinical Center awarded a purchase order to Omixon, Inc. for $101,220.00 on May 18, 2018, with an ultimate completion date of October 31, 2018. The order, issued as a firm fixed-price acquisition without set-aside, covers reagents for HLA genotyping and related biomedical products. Place of performance is Bethesda, Maryland.
Quick answers
Who was awarded contract 75N90018P00461?
75N90018P00461 was awarded to Omixon, Inc. by NIH Clinical Center (National Institutes of Health) on May 18, 2018.
How much is contract 75N90018P00461 worth?
The government has obligated $101,220 on 75N90018P00461.
Was contract 75N90018P00461 competed?
The extent of competition for 75N90018P00461 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award